Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548i-1 (MIR548I1) is a member of the miR-548 family, a group of short (20–24 nucleotide) non-coding RNAs that regulate gene expression at the post-transcriptional level in multicellular organisms. miRNAs generally function by binding to partially complementary sequences in target messenger RNAs (mRNAs), leading to inhibition of translation or degradation of the target mRNA. Members of the miR-548 family are implicated in diverse biological processes, particularly in cancer biology through the regulation of cell proliferation, apoptosis, migration, invasion, and epithelial-mesenchymal transition. Specific data on the function and disease relevance of MIR548I1 remain limited, but the broader miR-548 family is noted for variable expression patterns in tumors and a putative role as tumor suppressors or oncogenes depending on context[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 548i-1 (MIR548I1).